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Background: Tuberculosis is currently the second highest cause of death from infectious diseases worldwide. The
emergence of multi and extensive drug resistance is threatening to make tuberculosis incurable. There is growing
evidence that the genetic diversity of Mycobacterium tuberculosis may have important clinical consequences.
Therefore, combining genetic, clinical and socio-demographic data is critical to understand the epidemiology of
this infectious disease, and how virulence and other phenotypic traits evolve over time. This requires dedicated
bioinformatics platforms, capable of integrating and enabling analyses of this heterogeneous data.
Results: We developed inTB, a web-based system for integrated warehousing and analysis of clinical, socio-
demographic and molecular data for Mycobacterium sp. isolates. As a database it can organize and display data
from any of the standard genotyping methods (SNP, MIRU-VNTR, RFLP and spoligotype), as well as an extensive
array of clinical and socio-demographic variables that are used in multiple countries to characterize the disease.
Through the inTB interface it is possible to insert and download data, browse the database and search specific
parameters. New isolates are automatically classified into strains according to an internal reference, and data
uploaded or typed in is checked for internal consistency. As an analysis framework, the system provides simple,
point and click analysis tools that allow multiple types of data plotting, as well as simple ways to download data for
external analysis. Individual trees for each genotyping method are available, as well as a super tree combining all of
them. The integrative nature of inTB grants the user the ability to generate trees for filtered subsets of data crossing
molecular and clinical/socio-demografic information. inTB is built on open source software, can be easily installed
locally and easily adapted to other diseases. Its design allows for use by research laboratories, hospitals or public
health authorities. The full source code as well as ready to use packages is available at www.evocell.org/inTB.
Conclusions: To the best of our knowledge, this is the only system capable of integrating different types of
molecular data with clinical and socio-demographic data, empowering researchers and clinicians with easy to use
analysis tools that were not possible before.Background
Tuberculosis (TB) is usually a chronic, slowly progressing
disease that frequently remains undiagnosed for many
years. One-third of the world population is thought to be
infected and in 2010 there were around 9 million new
active cases of TB [1]. It is the second highest cause of
death from an infectious disease worldwide, after HIV,* Correspondence: jleal@igc.gulbenkian.pt
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reproduction in any medium, provided the orand the biggest killer of people infected with HIV [2]. The
rapid evolution of drug resistance strains is threatening to
make TB incurable.
To control the progression of this disease, we need to
define risk factors for transmission. To accomplish that,
we need detailed clinical and socio-demographical infor-
mation. In scenarios of intense transmission, it is essen-
tial to identify the source patient in order to prevent
activation of recent infections. On the other hand, in
communities where transmission is rare, the main goal
would be to identify people who are latently infected,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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reactivated latent infection [3,4].
Another question that remains unanswered is whether
specific characteristics are features of individual strains
or broader strain lineages. Defining the nature of diver-
sity in M. tuberculosis offers an ideal starting point for
evaluating the clinical implications of such diversity
[4-6]. The properties required to address the bacterial
diversity are unlikely to be met by a single marker. Since
standard sequence-based genotyping, such as Multilocus
sequence typing (MLST) is not applicable in these
bacteria, non sequence-based tools such as Variable
Number Tandem Repeat (VNTR) based techniques have
become the gold standard for routine genotyping and
have been successfully applied to answer a variety of epi-
demiological questions [2,7-10]. While the significance
of deep phylogenetic information for molecular epidemi-
ology is yet to be established, unequivocal classification
of bacterial strains is essential, in fact crucial if pheno-
typic associations are to be unveiled [6,7]. One way to
address this problem is to combine different typing
methods in order to take full advantage of their combined
results. IS6110 RFLP, MIRU-VNTR and spoligotyping are
methods that can be used for epidemiological purposes
but, unlike SNPs, they do not provide a robust phyloge-
netic picture [11,12].
Addressing these questions requires an integrated
framework, capable of linking clinical and socio-
demographic data with molecular data. This framework
should be able to read sequence data from bacterial
isolates, identify global patterns and automatically clas-
sify strains into families [4,13]. Currently there are a few
excellent public databases and web tools focused on
tuberculosis. SpolDB4 [14] provides a clear picture of
the current M. tuberculosis complex genome diversity,
through Spoligotypes, with around 2000 sequences
representative of several regions of the world. Never-
theless, it is not possible to correctly define the phylo-
genetic relationship of different strains only through
Spoligotypes. MIRU-VNTRplus [15] and SITVIT [16]
are broader than SpolDB4; they allow users to analyze
and compare genotypes based on several methods:
spoligotype, MIRU-VNTR, LSP, SNP or a combination
of these markers. Although these databases contains
information about sensitivity to drugs, little or no
clinical data is available nor can it be uploaded, and
without this information it is not possible to address
the questions raised above.
Other existing approaches, not specific to tuberculosis,
allow users to upload and analyze their data, such as
MLST [17,18]. MLST is used by public health labora-
tories and researchers to query nucleotide data against
databases over the Internet, but this system lacks
clinical and/or socio-demographic information anddoes not provide any tools to analyze the data. Other
systems have been designed for local installation, such
as EpiPATH [19] developed as a generic framework for
managing clinical and molecular data from infectious
diseases. However, EpiPATH lacks any analysis tools,
and requires programming-dependent customization to
be used for a complex disease such as tuberculosis,
with multiple typing methods and complex clinical
data. Finally, generic systems like Bionumerics by
Applied Maths NV. are widely used as data mana-
gement and analysis tools, but they are commercial
and costly.
While all the databases/platforms described above
have their merits, none provides a means to locally inte-
grate and analyze the complexity of tuberculosis within
the context of a research, public health or clinical unit.
In this work we describe a novel integrative framework,
inTB, developed to fill this gap. It is a free, locally install-
able, customizable data management and analysis system
for Mycobacterium disease, aimed at the research labora-
tories, public health authorities, and potentially for the
clinical setting. inTB integrates different types of mo-
lecular data with clinical and socio-demographic infor-
mation, and provides pre-defined data analysis and
reporting tools. Adoption of this system ensures data
consistency by use of validation mechanisms, and
data reusability, by use of the provided analysis tools.
inTB contrasts with existing dedicated databases and
tools (see above) by providing local data management
and analysis. It thus addresses privacy and confiden-
tiality concerns by providing easy-to-use packages for
local installation and use, without requiring that sen-
sitive information is transmitted over the Internet.
Furthermore, inTB brings to the fore extensive clin-
ical and socio-demographic data that can be analyzed
together with genotypic information, and should the
user wish to do so, it is simple to expand to include
more variables. InTB was designed bearing in mind
both the needs of our collaborators at the National
Tuberculosis Program in Portugal (Programa Nacional
de Luta Contra a Tuberculose), a national public health
authority, and our own needs as research labora-
tories investigating the molecular epidemiology of
M. tuberculosis.
Construction and content
Database schema
inTB was designed to integrate all major aspects of TB
infection. This is reflected in the database schema, which
consists of three major blocks: clinical, socio-demographic
and molecular information. Each of these are linked via a
clinical episode, which is the main entity of the schema,
therefore it is extremely important to correctly understand
the definition of ‘episode’. Episode refers to a single
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base corresponds to a diagnosis, which means that a pa-
tient can have more than one episode. If the patient has
two occurrences at different times he will have two epi-
sodes that can have clinical and/or socio-demographic
characteristics. The definition of ‘episode’ as the main unit
was necessary to deal with cases of sequential occurrences
of disease. Thus each individual case of tuberculosis can
be associated with different clinical, socio-demographic or
molecular information. Figure 1 represents the general
schema of inTB.
The clinical part of the database stores information on
BCG scar, vaccination and revaccination, diagnosis,
symptoms, appointment date, number of previous regi-
mens, toxicity, predicted period for completion of treat-
ment, radiology, clinical form, and several others. While
the socio-demographic part of the database has informa-
tion on gender, country of origin, geographical locali-
zation, education and risk factors, such as, if the patient
smokes, is drug dependent, alcoholic, unemployed,
among others. An additional block for contact informa-
tion include tables for the relationship with the contact
(family member, neighbor, coworker, etc.) as well as a
table for the symptoms.
On the molecular part of the database, there is a separ-
ate table for each of the typing methods: Spoligotype, SNP
(information on the SNPs used can be found here: [20]).
MIRU-VNTR and RFLP. An additional table stores the
individual strain predictions for each of these genotyping
methods, for each isolate, since there can be conflicts
about lineage identification between different methods
(see below). A separate table is used to associate each
sample to the episode it was identified in. Tables for first
and second line drug resistance are available, includingFigure 1 Overview of inTB. The system takes as input molecular typing, c
database. inTB allows users to analyze their data, identify lineages and to etables with the antibiotics used. Additional file 1 repre-
sents the complete database schema for all tables.
Each episode can have more than one sample, which
allows for the identification of possible co-infections, but
a single sample cannot belong to a different patient. The
episode table is used to traverse all relationships between
the three different blocks of the database. In case one of
the blocks of information is not provided, the system is
still able to perform correctly. The stored information is
displayed via a web interface, either textual or graphic-
ally (described below).Implementation
inTB is written in Python 2.6.5, can be installed on
UNIX/Linux systems and virtualized on Microsoft
Windows and Mac OSX. To store the information, a
MySQL server version 5.1 was used. The system was
implemented on Django 1.4 and runs on Apache with
mod_WSGI. Phylogenetic trees were built with BioPython
1.54 and NetworkX 0.99.
Access to inTB is made via a web browser. This choice
removes the need for any additional software installation
as all systems have a working web browser. Additionally,
it gives the user the possibility of using either as a local
system (local database), but also to be used with a cen-
tralized server with multiple distributed clients. inTB is
compatible with most common browsers. The oldest
recommended versions that were successfully tested are
Mozilla Firefox 3.6, Apple Safari 5.1, Microsoft Internet
Explorer 9 and Google Chrome 18. Newer versions were
also tested successfully. As long as browsers remain
compliant with HTML and CSS2/3 standards, future
versions should work without problems. To enable thelinical and socio-demographic data that is stored in a relational
xport data for external analyses.
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enabled.
To facilitate the use of inTB and avoid installation
problems, we provide a pre-built virtual machine to
be executed in the VirtualBox platform. The user has
only to follow some simple steps and s/he is able to
access the data through the web interface. For non-
programmer users this is an advantage because no
programming is needed. The virtual machine allows users
to run their own versions of inTB on their computers
without the need to code anything. Once the system is
locally installed, no additional connection to the Internet
is necessary.Utility and discussion
Data input
inTB was initially built for our own use (bioinformatics,
genetics and epidemiology groups) and that of our col-
laborators (public health authorities, clinical groups).
We made most of the features accessible via a graphical
interface. This interface provides two ways to insert data;
manual insertion via a form, or by uploading a comma
separated value (CSV) file. Additionally, users may also
insert data directly into the database by writing custom
scripts. inTB includes verifications of variable type and
term matching to minimize errors when uploading data.
Detailed instructions on how to upload data are given in
the manual, but a few points merit mention here. The
first is that inTB automatically creates an episode
number for each patient when new data is inserted.
Since each patient has a unique identifier, this means
that inTB can track multiple episodes per patient. The
second is that a patient identifier is not required for
molecular and resistance data, only a sample code is
required. This enables the asynchronous uploading of
data that can later be linked, when further data be-
comes available. The third point is that when adding
new variables to the database, inTB encourages stan-
dards compliance, connecting the user to BioPortal
[21] - a list of BioPortal terms used inTB is provided
in Additional file 2. Finally, in its current implemen-
tation, inTB will integrate four types of genotypic
data. However, inTB does not process as yet raw
genotypic information for any method, which need to
be transformed into a text file externally (SNP letter/
positions, MIRU numbers, spoligotype and RFLP bin-
ary patterns).
inTB may be the first data management solution that a
given user will have, or it will be used alongside existing
data management solutions. In the latter case, data
transfer solutions between existing systems and inTB
will need to be implemented. Laboratories that generate
molecular typing information on a routine basis will verylikely have some sort of LIMS (Laboratory Information
Management Systems) from which the molecular data
will need to be exported to be uploaded to inTB. It may
be used alongside or instead existing databases in public
health laboratories/authorities. In our experience, deal-
ing with data management systems from the Portuguese
public health authorities and the Genotyping Laboratory
at the Instituto Gulbenkian de Ciência, we solved this
problem by implementing a semi-automated exporting
of spreadsheets and simple scripts to format the data
and upload it to inTB. Another problem that the user
may experience is having data types that are not
present in inTB. Since inTB is built upon open access
tools, adding additional fields to the database is fea-
sible and simple, but it will require some programing
knowledge.
Data access
There are two major ways to access data via the web
interface: browsing the content and searching for
particular episodes, filtering by one of several criteria.
Both methods result in the same output, the results page
(Figure 2). This gives an overview of the most relevant
information for each patient, and is likely of interest to
researchers wishing to find trends in data. The user can
download the data for external analysis.
The focus on patient was designed with clinical use at
heart. It displays information about the current other
episode of disease, follow-up and contact. The latter was
included at the requests of clinicians, wishing to have
the means to rapidly contact patients following a diagno-
sis of the disease, in order to to prevent other infections
or quickly diagnose other patients. The inclusion follow-
up information allows the monitoring of the progress
of the status of the patient, allowing for quick diagno-
sis of possible reinfections, decreasing the risk of death
and transmission in the community. Different episodes
may be chosen for comparison of clinical and socio-
demographic information, side by side. As before,
when episodes are selected, it is possible to download all
the information associated (clinical, socio-demographic
and molecular).
Data analysis
One of the novel features of this database, compared to
existing resources, are the analysis tools provided.
Within the analysis menu, the user can have a global
overview of the data in the database, plotted according
to different criteria. Every time new data is entered into
the system, all the plots and dendograms are automa-
tically updated. The user may also select a subset of data
and/or variables for plotting. Moreover the user can
download the raw data used to create each result in case
they want to perform their own analysis with another
Figure 2 Results page. It can be accessed via the browse or search functions, or as in the case shown, for a subset of isolates that were
selected by the user.
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interface, four of which we illustrate below, with an em-
phasis on phylogenetic analysis.
inTB can generate and display phylogenetic trees, and
it automatically classifies new isolates added to the data-
base into pre-defined tuberculosis families. We compiled
SNPs and specific spoligotype patterns from the litera-
ture allowing to unambiguously identify the lineages
[14,22-24]. As soon as new molecular data is uploaded
into inTB, the system will automatically align the samples,
build a tree and color each sample according to a specific
lineage. inTB builds a maximum likelihood tree, using
PhyML [25], for SNPs, based on an alignment performed
with Mauve [26]. For the three other methods, inTB
calculates a Neighbor-Joining tree, based on a distance
matrix calculated according to the Manhattan distance
(MIRU-VNTR) or Hamming distance (RFLP/Spoligotype).
The phylogenetic tree for RFLP was built through a binary
file exported from Bionumerics [27]. Note that if the user
wants to use another phylogenetic method, the alignment
is provided for download. We show in Figure 3A the out-
put of a SNP analysis, and it reveals for example that the
LAM lineage dominates the population in the database,
followed by Harlem, and that while the latter is not very
diverse, the former shows considerable diversification.
The user is given also the option of generating trees based
on a subset of the data (e.g. all the isolates from 2010
onwards).Tuberculosis typing methods have varied over time,
and new methods tend to supersede older ones. This
means that for older data we may have a dominance of
one method (RFLP, Spoligotype), but for new isolates
MIRUs and SNPs may dominate. To enable users to deal
with this data heterogeneity, inTB can also calculate
supertrees. A supertree is a phylogenetic tree assembled
from a combination of smaller phylogenetic trees. By
combining the phylogenetic tree obtained by SNPs,
MIRUs, Spoligotype and RFLP, a single, comprehensive
tree called supertree is created. This supertree is built
with Matrix Representation Parsimony (MRP). This
method converts each tree into a matrix of binary char-
acters. All the matrices are then combined into a single
matrix, with question marks in any cell for a sample not
found in a particular clade. The parsimony tree is the
supertree. Note that the use of supertrees is controver-
sial [28,29].
In Figure 3B we show a temporal analysis of all spe-
cies. Other variables could be plotted over time such as
the incidence of drug resistance. Figure 3C shows a
heatmap comparing recurrence patterns - if a patient
has a recurrence, this heatmap allows reveals whether
they are by the same or a different species. SNPs in-
volved in the development of resistance are powerful
markers for detection of first and second line resistance.
Users can generate bar charts of SNP frequency, for ex-
ample as a function of drug resistance (Figure 3D).
Figure 3 Screenshots of some analyses features offered by inTB. (A) SNP-based dendogram of strains in database (B) Infections over time,
by species - the two lines represent unclassified (top) and M. tuberculosis (middle), with all other species close to or at zero (C) Recurrence matrix
by species highlighting the rare occurrences of reinfections (D) Frequency of antibiotic resistances per SNP (SNP shown is in the gene rpoB,
which is known to be involved in resistance to Rifampicin - dark green represent the reference allele).
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online. However, we considered that our target audience
needs to have the results in different formats - to
present results in conferences or seminars, or as recur-
rent reports in case of public health laboratories/clinical
centers. We have thus implemented the option of creat-
ing pre-defined reports that generates tables and charts
in either a PDF or a CSV format. We pre-defined five
types of reports as example: (i) variation of gender and
resistance over time, (ii) occurrence of new cases, (iii)re-treatment over time, (iv) proportion of episodes oc-
curring in immigrants, with information of the country
of origin, as well as the (v) percentage of missing data,
for each variable, according to the selected year. The
user is able to select the variable of interest and generate
a PDF or CSV report.
Testing/usability
An empirical usability test was performed in order to to
determine whether the design and tools implemented
Table 1 Summary of the characteristics of the
participants in the usability test
Characteristics Value
Number of participants 16
Average age 34 years
Academic studies 43.75% bioinformatics,
18,75% maths,
12.5% biochemistry,
6.25% computer science,
6.25% medicine,
6.25% biology.
Gender 62.5% Male, 37.5% Female
Previous experience with databases 75% Yes, 25% No
Experience with tuberculosis 32% Yes, 68% No
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interface, and to identify the main difficulties while
navigating through the website. The test involved 16 par-
ticipants with different backgrounds, as given on Table 1.
We used time to complete each task as the metric in this
test. Subjects read a short tutorial and were then asked
to complete several tasks on a test database (Additional
file 3) - the time that each task took to complete was
recorded for each participant independently. One of the
authors also did the test to give us a reference (shortest)
time. The main results are summarized in Table 2. Over-
all the users did not have problems in quickly solving
the problems in the test, nor did they take much time to
do so, considering that for most of them it was the first
contact with the website. In all the cases where users
took a bit longer or reported a higher difficulty were
simplified as per user’s suggestions. Note that this is aTable 2 Summary of the results of the usability test, for
the test population shown in Table 1, and for one of the
developers (PS), given as reference time
Task Average time, in seconds Reference time, in seconds
1 41.1 (17.9 – 90.6) 4.2
2 82.2 (57.3 – 113.3) 22.7
3 76.7 (17.5 – 215) 9
4 68.6 (20–130) 18
5 108.9 (38–270) 23
6 28.6 (6.7 – 48.7) 6.2
7 74.5 (15–155) -
Five tasks were considered: (1) Browsing through the data, (2) Entering data
into the system, (3) Searching specific episodes, (4) Updating records, (5)
Generate reports, (6) Analyze several graphics and (7) locally install inTB and
access it.second test, as earlier in the development phase we
conducted a smaller heuristic evaluation [30] of inTB to
identify problems and avenues for improvement - user’s
suggestions at that stage were particularly important
when implementing the final design of the site.Conclusions
inTB is an open source information system for stor-
ing, managing and analyzing data from clinical and
molecular information on tuberculosis, which is avail-
able for download and local installation. This system
allows identification of lineages of M. tuberculosis
strains based on different genotyping methods. Fur-
thermore inTB combines this information with clin-
ical and socio-demographic information, allowing new
types of analyses. inTB was conceived to be used both
in the research laboratory, and by public health or
clinical centers. It is currently used within a research
setting at the Instituto Gulbenkian de Ciência, in a
collaborative project with public health authorities in
Portugal. Its adaptation to other infectious diseases is
being discussed with the Portuguese National Health
Institute. We believe that inTB fills the gap of a free
software that can simultaneously store and analyze
epidemiological data for tuberculosis, for use by re-
searchers, clinicians and public health authorities, and
that provides both the easy to use web-based inter-
face for the non-programers, as well as the normal
programatic access of open access platforms.Availability and requirements
A demo version of inTB is available at www.evocell.org/
inTB. At the same address an installation version, and a
virtual machine image, can be downloaded. inTB runs
on Unix/Linux and can be virtualized in Mac OSX and
Windows systems. It has been tested in a variety of
browsers (Mozilla Firefox 3.6, Apple Safari 5.1, Microsoft
Internet Explorer 9 and Google Chrome 18). inTB is
distributed under a BSD 3-clause license.Additional files
Additional file 1: Detailed inTB DB schema.
Additional file 2: Summary of ontology terms used.
Additional file 3: inTB usability test.
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